Incepto Medical SAS

Founded in 2018, Incepto Medical SAS specializes in developing medical imaging software that enhances diagnostic processes in healthcare settings. The company is headquartered in Paris, France. Co-founders Antoine Jomier, Florence Moreau, Gaspard d'Assignies, Jerome Vadon, and Vincent Barrau bring diverse expertise to the firm. In September 2022, Incepto Medical raised EUR 27 million in a Series B funding round led by LBO France, with participation from AXA Venture Partners, Bpifrance Investissement, Karista, and Wille Finance, bringing the total amount raised to EUR 27 million.

The firm has completed two deals to date. Incepto Medical specializes in developing innovative medical imaging solutions designed to enhance diagnostic accuracy and efficiency for healthcare providers. Their core offerings include advanced software platforms that utilize artificial intelligence to improve the interpretation of medical images, streamlining workflows for radiologists and clinicians. The solutions address critical use cases such as early detection of diseases, improved treatment planning, and reduced diagnostic errors, catering to hospitals, radiology practices, and healthcare networks across Europe and North America, particularly in France, Germany, and the United States.

Continuous updates and enhancements keep the products aligned with technological advancements and user feedback. Incepto Medical generates revenue through a combination of subscription models and partnerships with healthcare institutions. Clients engage in direct transactions for software licenses or annual subscriptions that provide ongoing access to updates and support services. The pricing structure is tiered, allowing healthcare providers to select plans based on their specific needs and deployment scale.

Flagship offerings include proprietary software tailored for specific imaging modalities, ensuring they meet end-user demands across diverse clinical settings, facilitating a steady revenue stream while fostering long-term relationships with healthcare providers. In September 2022, Incepto Medical SAS raised EUR 27 million in Series B funding, which will be utilized to enhance their development efforts within the European market. The company plans to introduce new products aimed at improving diagnostic capabilities, continuing its commitment to innovation in medical imaging. Incepto Medical also intends to expand into additional markets across Europe by 2024, leveraging the recent funding to support these growth initiatives.